explore -WSS

explore

author：focus 2025-10-01 23:01:47 - browse：8475

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Option Care buys Amedisys in $3.6 billion home care deal

entertainment

WSS

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Grail is spending more than ever lobbying Congress

PhRMA sues HHS over Medicare drug price negotiation

7 people shot in DC, police say

Why you get paid to donate plasma but not blood

Connecting traumatic brain injury and domestic violence

hotspot

explore

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

PhRMA sues HHS over Medicare drug price negotiation

Trump demands the U.S. pay no more for drugs than other countries … again

4th of July breaks record for highest global temperature ever measured

The high cost of giving birth even with insurance

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Jerome Adams on the need for new antivirals for Covid

Can food be medicine? And other questions about a new push

What does generative AI mean for health care? We asked experts

Study: Hearing aids may slow cognitive decline in those at risk

Wikipedia

Did the public have the right to know Arthur Ashe had AIDS?

Robert Kennedy Jr.'s presidential campaign attracts GOP

Make 'food is medicine' a key part of White House nutrition meeting

PhRMA sues HHS over Medicare drug price negotiation

BridgeBio heart drug succeeds in pivotal study

Community addresses injustice for Long Island mothers

knowledge

entertainment

hotspot

hotspot